Infection of point-of-lay hens to assess the sequential events during H7N7 high-pathogenicity avian influenza emergence at a layer premises

IF 2.6 3区 医学 Q3 VIROLOGY
Virology Pub Date : 2026-02-01 Epub Date: 2025-10-31 DOI:10.1016/j.virol.2025.110733
Amanda H. Seekings , Elizabeth Billington , Sahar Mahmood , Saumya S. Thomas , Anita Puranik , Simon Johnson , Alejandro Nunez , Samantha Watson , Jill Banks , Sharon M. Brookes , Ian H. Brown , Marek J. Slomka
{"title":"Infection of point-of-lay hens to assess the sequential events during H7N7 high-pathogenicity avian influenza emergence at a layer premises","authors":"Amanda H. Seekings ,&nbsp;Elizabeth Billington ,&nbsp;Sahar Mahmood ,&nbsp;Saumya S. Thomas ,&nbsp;Anita Puranik ,&nbsp;Simon Johnson ,&nbsp;Alejandro Nunez ,&nbsp;Samantha Watson ,&nbsp;Jill Banks ,&nbsp;Sharon M. Brookes ,&nbsp;Ian H. Brown ,&nbsp;Marek J. Slomka","doi":"10.1016/j.virol.2025.110733","DOIUrl":null,"url":null,"abstract":"<div><div>H7N7 low-pathogenicity avian influenza virus (H7N7-LPAIV) incursions preceded emergence of H7N7 high-pathogenicity (HP)AIV at several European layer hen outbreaks. Evidence from a UK layer H7N7-HPAIV (2008) outbreak informed <em>in vivo</em> modelling of sequential events, beginning with H7N7-LPAIV precursor incursion. Three groups of 17-week-old (point-of-lay) hens were inoculated with H7N7-LPAIVs, which possessed different haemagglutinin cleavage sites (CS). Groups 1 and 2 were inoculated with H7N7-LPAIVs which possessed single and di-basic cleavage sites (SBCS and DBCS, the latter having occurred at the 2008 outbreak), along with the H7N7-HPAIV's internal genes. Group 3 was inoculated with a contemporary H7N7-LPAIV which possessed the DBCS, but different internal genes. In Groups 1–3, initial H7N7-LPAIV exposure caused limited viral shedding, restricted H7-antibody responses and no deaths by 14-days post-inoculation (dpi). H7N7-HPAIV challenge of all groups (n = 8 per challenge group, including AIV-naïve hens in Group 4) followed at 14 dpi, with 3/8 (37.5 %) survival in Group 4, by 14-days post-challenge (dpc). Prior H7N7-LPAIV inoculation protected against H7N7-HPAIV challenge mortality to varying degrees (6/8-8/8 [75 %–100 %] survival range) by 14 dpc, when all 21 Group1-3 survivors had strongly seroconverted. Among these survivors, 20/21 (95 %) shed H7N7-HP, indicating that immunity acquired during initial H7N7-LPAIV exposure did not arrest H7N7-HPAIV replication. Prior H7N7-LPAIV exposure elicited clinical protection against H7N7-HPAIV challenge, but did not prevent H7N7-HPAIV shedding, which in the field would represent a potential source for spread and further HPAIV outbreaks.</div></div>","PeriodicalId":23666,"journal":{"name":"Virology","volume":"614 ","pages":"Article 110733"},"PeriodicalIF":2.6000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042682225003472","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

H7N7 low-pathogenicity avian influenza virus (H7N7-LPAIV) incursions preceded emergence of H7N7 high-pathogenicity (HP)AIV at several European layer hen outbreaks. Evidence from a UK layer H7N7-HPAIV (2008) outbreak informed in vivo modelling of sequential events, beginning with H7N7-LPAIV precursor incursion. Three groups of 17-week-old (point-of-lay) hens were inoculated with H7N7-LPAIVs, which possessed different haemagglutinin cleavage sites (CS). Groups 1 and 2 were inoculated with H7N7-LPAIVs which possessed single and di-basic cleavage sites (SBCS and DBCS, the latter having occurred at the 2008 outbreak), along with the H7N7-HPAIV's internal genes. Group 3 was inoculated with a contemporary H7N7-LPAIV which possessed the DBCS, but different internal genes. In Groups 1–3, initial H7N7-LPAIV exposure caused limited viral shedding, restricted H7-antibody responses and no deaths by 14-days post-inoculation (dpi). H7N7-HPAIV challenge of all groups (n = 8 per challenge group, including AIV-naïve hens in Group 4) followed at 14 dpi, with 3/8 (37.5 %) survival in Group 4, by 14-days post-challenge (dpc). Prior H7N7-LPAIV inoculation protected against H7N7-HPAIV challenge mortality to varying degrees (6/8-8/8 [75 %–100 %] survival range) by 14 dpc, when all 21 Group1-3 survivors had strongly seroconverted. Among these survivors, 20/21 (95 %) shed H7N7-HP, indicating that immunity acquired during initial H7N7-LPAIV exposure did not arrest H7N7-HPAIV replication. Prior H7N7-LPAIV exposure elicited clinical protection against H7N7-HPAIV challenge, but did not prevent H7N7-HPAIV shedding, which in the field would represent a potential source for spread and further HPAIV outbreaks.
蛋鸡疫点感染评估鸡舍出现H7N7高致病性禽流感的顺序事件。
H7N7低致病性禽流感病毒(H7N7- lpaiv)的入侵先于H7N7高致病性(HP)AIV在欧洲几次蛋鸡暴发的出现。来自英国2008年h7n9 - hpaiv暴发的证据为从H7N7-LPAIV前体入侵开始的连续事件的体内模型提供了信息。将3组17周龄母鸡接种具有不同血凝素裂解位点(CS)的h7n7 - lpaiv。第1组和第2组接种具有单碱基和双碱基裂解位点(SBCS和DBCS,后者在2008年爆发时发生)的h7n9 - hpaiv,以及H7N7-HPAIV的内部基因。第三组接种具有DBCS但内部基因不同的当代h7n9 - lpaiv。在1-3组中,最初接触h7n9 - lpaiv导致有限的病毒脱落,限制了h7抗体反应,接种后14天(dpi)无死亡。各组(每个攻毒组n = 8只,第4组AIV-naïve鸡)攻毒后14 d,第4组3/8(37.5%)存活。当21名第1-3组幸存者血清转化强烈时,既往接种H7N7-LPAIV可不同程度地保护死亡率(6/8-8/8[75% - 100%]生存范围)14个百分点。在这些幸存者中,20/21(95%)感染了H7N7-HP,这表明在初次接触H7N7-LPAIV时获得的免疫并没有阻止H7N7-HPAIV的复制。先前的H7N7-LPAIV暴露引起了临床对H7N7-HPAIV攻击的保护,但并没有阻止H7N7-HPAIV的脱落,这在现场可能是HPAIV传播和进一步暴发的潜在来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Virology
Virology 医学-病毒学
CiteScore
6.00
自引率
0.00%
发文量
157
审稿时长
50 days
期刊介绍: Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinologists and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work.Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书